Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma is a research paper published in Oncotarget (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: P30 CA076292
NCI NIH HHS
Grant: R01 CA243577
NCI NIH HHS
Grant: R01 CA263575
National Institutes of Health
Grant: 5R01CA243577-04
Targeted inhibition in stromal TGFβ activity in pancreatic cancer
National Institutes of Health
Grant: 3P30CA076292-24S2
Moffitt Cancer Center Support Grant
FWCI
0.41
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals